Quote Level 2 Charts News Trades Historical Financials Wiki Message Board

Cannabis Science, Inc. (PC) (CBIS)

$ 0.033 ▼-0.0047 (-12.47%)
Volume: 4,110,875
Add CBIS To StreamerAdd CBIS To Streamer
Add CBIS To My StocksAdd CBIS To My Stocks
Add CBIS Price AlertAdd CBIS Price Alert
Bid Ask Last Traded Open Prev Close
0.033 0.0345 3:59:44 PM EST 0.038 0.0377
Day's Range 52-Wk Range Avg Volume EPS P/E
0.0315 - 0.0385 0.0127 - 0.0995 6.83M N/A N/A
Market Cap Outstanding Float Dividend / Yield Ex-Div Date
45.63M 1.19B 24.00M N/A N/A
Short Interest Short % of Out Insider B/S Inst % Owned Exchange
36,229 0.00 % N/A N/A USOTC
Support 2 Support 1 Pivot Price Resistance 1 Resistance 2
$ 0.0273 $ 0.0302 $ 0.0343 $ 0.0372 $ 0.0413
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Mon Aug 24,2015 2:03 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
Edgar (US Regulatory) • Mon Aug 17,2015 4:51 PM
Quarterly Report (10-q)
Edgar (US Regulatory) • Tue Jul 28,2015 1:01 PM
Current Report Filing (8-k)
Edgar (US Regulatory) • Tue Jun 30,2015 6:06 AM
Amended Statement of Changes in Beneficial Ownership (4/a)
Edgar (US Regulatory) • Thu Jun 18,2015 6:35 PM
Amended Statement of Changes in Beneficial Ownership (4/a)
Edgar (US Regulatory) • Thu Jun 18,2015 6:30 PM
Amended Statement of Changes in Beneficial Ownership (4/a)
Edgar (US Regulatory) • Thu Jun 18,2015 6:24 PM
Amended Statement of Beneficial Ownership (3/a)
Edgar (US Regulatory) • Thu Jun 18,2015 6:03 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Tue Jun 16,2015 5:45 PM
Amended Annual Report (10-k/a)
Edgar (US Regulatory) • Thu Jun 11,2015 1:48 PM
Statement of Changes in Beneficial Ownership (4)
Edgar (US Regulatory) • Wed Jun 10,2015 6:54 PM
Cannabis Science Brings CS-TATI-1 to the FDA with Historic Collaborative Drug Development Deal With IGXBio and Its GenePro®,...
PR Newswire (US) • Wed May 27,2015 8:05 AM
Link to Cannabis Science, Inc. (PC) Stock Price

Cannabis Science, Inc. (PC) Company Description


Cannabis Science, Inc., takes advantage of its unique understanding of metabolic processes to provide novel treatment approaches to a number of illnesses for which current treatments and understanding remain unsatisfactory. Cannabinoids have an extensive history dating back thousands of years, and currently, there are a growing number of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment for illnesses caused by infections as well as for age-related illness. Our initial focus is on skin cancers, HIV/AIDS, and neurological conditions. The Company is proceeding with the research and development of its proprietary drugs as a part of this initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1, respectively.

CBIS Intraday Stock Chart

1d 1m 3m 6m 1y 2y 5y


CBIS vs ETF alternatives
ETFsToday3mths1YrYTD
CBIS-12.47%8.91%-53.72%-47.49%
IJR-0.08%-5.93%0.22%-1.49%
EES0.61%-8.48%-5.21%-5.19%
SCHA-0.47%-7.73%-1.79%-2.63%
VIOO0.10%-5.69%0.52%-1.46%
VB-0.51%-7.22%-2.40%-1.93%
DWAS-0.80%-3.41%3.22%2.90%
SAA-0.16%-11.85%-50.28%-53.15%



Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.